SCHEMBL6389919

SCHEMBL6389919

O=C(O)c1cccc2cc(S(=O)(=O)O)cc(C(=O)O)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.49
▸ ALDH1A1 P00352 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ LCK P06239 1/20 0.43
▸ FYN P06241 1/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ NR4A1 P22736 1/20 0.42
▸ NR4A2 P43354 1/20 0.42
▸ NR4A3 Q92570 1/20 0.42
▸ CTDSP1 Q9GZU7 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PTPN1 P18031 1/20 0.40
▸ APEX1 P27695 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7665161 0.98 HSD17B10 (0.47) HSD17B10ALDH1A1KDM4EHPGDLCK
SCHEMBL7822313 0.86 LCK (0.52) HSD17B10ALDH1A1KDM4EHPGDLCK
SCHEMBL7665156 0.84 DUSP5 (0.54) HSD17B10ALDH1A1KDM4EHPGDMEN1
SCHEMBL7192766 0.78 CYP2D6 (0.58) HSD17B10ALDH1A1KDM4EHPGDLCK
SCHEMBL11644409 0.77 SCN9A (0.41) HSD17B10ALDH1A1KDM4EHPGDMEN1
SCHEMBL9359948 0.77 SCN9A (0.41) HSD17B10ALDH1A1KDM4EHPGDMEN1
SCHEMBL10385032 0.77 PTPN1 (0.60) HSD17B10ALDH1A1KDM4EHPGDCYP2D6
SCHEMBL7543178 0.77 CYP2D6 (0.56) HSD17B10ALDH1A1KDM4EHPGDLCK
SCHEMBL5001925 0.76 KMT2A (0.50) HSD17B10ALDH1A1HPGDMEN1KMT2A
SCHEMBL10866993 0.75 PTPN1 (0.58) HSD17B10ALDH1A1KDM4EHPGDCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11315739-B2 Electrolytic capacitor and method for manufacturing same PANASONIC INTEILECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2022-04-26 — — US disclosed
CN-111630618-B Electrolytic capacitor and method for manufacturing the same 松下知识产权经营株式会社 2021-10-29 — — CN disclosed
CN-111630618-A Electrolytic capacitor and method for manufacturing the same 松下知识产权经营株式会社 2020-09-04 — — CN disclosed
US-20200279691-A1 ELECTROLYTIC CAPACITOR AND METHOD FOR MANUFACTURING SAME PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2020-09-03 — — US disclosed
US-20050040373-A1 Dopant and conductive polymer material therewith MITSUI CHEMICALS, INC. (JP) 2005-02-24 — — US disclosed
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same MITSUI CHEMICALS, INC. (JP) 2003-07-31 — — US disclosed
US-4212813-A OXIDIZING ACENAPHTHENES, COBALT COMPOUND CATALYST NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1980-07-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same RPS6, H1-10, H1-0 HSD17B10 3453/4885ALDH1A1 667/4885KDM4E 1906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback